Search Results - "TOGNONI, Gianni"

Why and how do we need comprehensive international clinical epidemiology of ARDS? by Tognoni, Gianni, Vivona, Luigi, Pesenti, Antonio

Get full text

Albumin Replacement in Patients with Severe Sepsis or Septic Shock by Caironi, Pietro, Tognoni, Gianni, Masson, Serge, Fumagalli, Roberto, Pesenti, Antonio, Romero, Marilena, Fanizza, Caterina, Caspani, Luisa, Faenza, Stefano, Grasselli, Giacomo, Iapichino, Gaetano, Antonelli, Massimo, Parrini, Vieri, Fiore, Gilberto, Latini, Roberto, Gattinoni, Luciano

“…In patients with severe sepsis, albumin replacement in addition to crystalloid administration conferred no benefit, as compared with crystalloids alone, with…”
Get full text

Health as a Human Right: A Fake News in a Post-human World? by Tognoni, Gianni, Macchia, Alejandro

“…Based on a synthetic overview that embraces the evolution of the ‘health’ concept, and its related institutions, from the role of health as the main indicator…”
Get full text

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials by Rothwell, Peter M, Prof, Price, Jacqueline F, MD, Fowkes, F Gerald R, Prof, Zanchetti, Alberto, Prof, Roncaglioni, Maria Carla, PhD, Tognoni, Gianni, Prof, Lee, Robert, MSc, Belch, Jill FF, Prof, Wilson, Michelle, BSc, Mehta, Ziyah, DPhil, Meade, Tom W, Prof

“…Summary Background Daily aspirin reduces the long-term risk of death due to cancer. However, the short-term effect is less certain, especially in women,…”
Get full text

Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial by Masson, Serge, Caironi, Pietro, Spanuth, Eberhard, Thomae, Ralf, Panigada, Mauro, Sangiorgi, Gabriela, Fumagalli, Roberto, Mauri, Tommaso, Isgrò, Stefano, Fanizza, Caterina, Romero, Marilena, Tognoni, Gianni, Latini, Roberto, Gattinoni, Luciano

“…Sepsis, a leading cause of death in critically ill patients, is the result of complex interactions between the infecting microorganisms and the host responses…”
Get full text

Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial) by Masson, Serge, PhD, Latini, Roberto, MD, Anand, Inder S., MD, FACC, FRCP, DPhil (Oxon), Barlera, Simona, MS, Angelici, Laura, MS, Vago, Tarcisio, BiolD, Tognoni, Gianni, MD, Cohn, Jay N., MD, FACC

“…Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial) Serge Masson, Roberto Latini, Inder S…”
Get full text

A reappraisal of the benefit‐risk profile of hydroxyurea in polycythemia vera: A propensity‐matched study by Barbui, Tiziano, Vannucchi, Alessandro Maria, Finazzi, Guido, Finazzi, Maria Chiara, Masciulli, Arianna, Carobbio, Alessandra, Ghirardi, Arianna, Tognoni, Gianni

“…The use of hydroxyurea (HU) as first line therapy in polycythemia vera (PV) has been criticized because no solid demonstration that this drug prevents…”
Get full text

Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain by Bandieri, Elena, Romero, Marilena, Ripamonti, Carla Ida, Artioli, Fabrizio, Sichetti, Daniela, Fanizza, Caterina, Santini, Daniele, Cavanna, Luigi, Melotti, Barbara, Conte, Pier Franco, Roila, Fausto, Cascinu, Stefano, Bruera, Eduardo, Tognoni, Gianni, Luppi, Mario

“…The WHO guidelines on cancer pain management recommend a sequential three-step analgesic ladder. However, conclusive data are lacking as to whether moderate…”
Get full text

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials by Sattar, Naveed, Prof, Preiss, David, Dr, Murray, Heather M, MSc, Welsh, Paul, PhD, Buckley, Brendan M, Prof, de Craen, Anton JM, PhD, Seshasai, Sreenivasa Rao Kondapally, MD, McMurray, John J, Prof, Freeman, Dilys J, PhD, Jukema, J Wouter, Prof, Macfarlane, Peter W, Prof, Packard, Chris J, Prof, Stott, David J, Prof, Westendorp, Rudi G, Prof, Shepherd, James, Prof, Davis, Barry R, Prof, Pressel, Sara L, MS, Marchioli, Roberto, Prof, Marfisi, Rosa Maria, Prof, Maggioni, Aldo P, Prof, Tavazzi, Luigi, Prof, Tognoni, Gianni, Prof, Kjekshus, John, Prof, Pedersen, Terje R, Prof, Cook, Thomas J, MS, Gotto, Antonio M, Prof, Clearfield, Michael B, Prof, Downs, John R, MD, Nakamura, Haruo, Prof, Ohashi, Yasuo, Prof, Mizuno, Kyoichi, Prof, Ray, Kausik K, MD, Ford, Ian, Prof

“…Summary Background Trials of statin therapy have had conflicting findings on the risk of development of diabetes mellitus in patients given statins. We aimed…”
Get full text

Circulating Biologically Active Adrenomedullin (bio-ADM) Predicts Hemodynamic Support Requirement and Mortality During Sepsis by Caironi, Pietro, Latini, Roberto, Struck, Joachim, Hartmann, Oliver, Bergmann, Andreas, Maggio, Giuseppe, Cavana, Marco, Tognoni, Gianni, Pesenti, Antonio, Gattinoni, Luciano, Masson, Serge, Masson, S., Caironi, P., Spanuth, E.

“…The biological role of adrenomedullin (ADM), a hormone involved in hemodynamic homeostasis, is controversial in sepsis because administration of either the…”
Get full text

Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials by Rossignol, Patrick, Masson, Serge, Barlera, Simona, Girerd, Nicolas, Castelnovo, Angelo, Zannad, Faiez, Clemenza, Francesco, Tognoni, Gianni, Anand, Inder S., Cohn, Jay N., Anker, Stefan D., Tavazzi, Luigi, Latini, Roberto

“…Aims Uncertainties remain on the biological and prognostic significance and therapeutic implications of loss in body weight (W‐LOSS) in chronic heart failure…”
Get full text

The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials by Preiss, David, Campbell, Ross T, Murray, Heather M, Ford, Ian, Packard, Chris J, Sattar, Naveed, Rahimi, Kazem, Colhoun, Helen M, Waters, David D, LaRosa, John C, Amarenco, Pierre, Pedersen, Terje R, Tikkanen, Matti J, Koren, Michael J, Poulter, Neil R, Sever, Peter S, Ridker, Paul M, MacFadyen, Jean G, Solomon, Scott D, Davis, Barry R, Simpson, Lara M, Nakamura, Haruo, Mizuno, Kyoichi, Marfisi, Rosa M, Marchioli, Roberto, Tognoni, Gianni, Athyros, Vasilios G, Ray, Kausik K, Gotto, Antonio M, Clearfield, Michael B, Downs, John R, McMurray, John J

“…The effect of statins on risk of heart failure (HF) hospitalization and HF death remains uncertain. We aimed to establish whether statins reduce major HF…”
Get full text

A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure by Cohn, Jay N, Tognoni, Gianni

“…Angiotensin II may contribute to the progression of heart failure. In this trial, valsartan, an angiotensin-receptor blocker, reduced the need for…”
Get full text

Clinical outcome of renal tubular damage in chronic heart failure by Damman, Kevin, Masson, Serge, Hillege, Hans L., Maggioni, Aldo P., Voors, Adriaan A., Opasich, Cristina, van Veldhuisen, Dirk J., Montagna, Laura, Cosmi, Franco, Tognoni, Gianni, Tavazzi, Luigi, Latini, Roberto

“…Aims Both reduced glomerular filtration and increased urinary albumin excretion independently determine outcome in patients with chronic heart failure (HF)…”
Get full text

Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p by Broadbent, Helen M., Peden, John F., Lorkowski, Stefan, Goel, Anuj, Ongen, Halit, Green, Fiona, Clarke, Robert, Collins, Rory, Franzosi, Maria Grazia, Tognoni, Gianni, Seedorf, Udo, Rust, Stephan, Eriksson, Per, Hamsten, Anders, Farrall, Martin, Watkins, Hugh

“…Genome-wide association studies have identified a region on chromosome 9p that is associated with coronary artery disease (CAD). The region is also associated…”
Get full text

A meta-analysis of trials of pulmonary hypertension: A clinical condition looking for drugs and research methodology by Macchia, Alejandro, MD, Marchioli, Roberto, MD, Marfisi, RosaMaria, MS, Scarano, Marco, MS, Levantesi, Giacomo, MD, Tavazzi, Luigi, MD, Tognoni, Gianni, MD

“…Background Various innovative pharmacologic strategies for the treatment of patients with pulmonary hypertension have been tested in recent years. Neither…”
Get full text

Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera by Marchioli, Roberto, Finazzi, Guido, Landolfi, Raffaele, Kutti, Jack, Gisslinger, Heinz, Patrono, Carlo, Marilus, Raphael, Villegas, Ana, Tognoni, Gianni, Barbui, Tiziano

“…The clinical course of polycythemia vera is often complicated by thrombosis as well as by the possible transition to myeloid metaplasia with myelofibrosis or…”
Get full text

The Drug Derived Complexity Index (DDCI) Predicts Mortality, Unplanned Hospitalization and Hospital Readmissions at the Population Level by Robusto, Fabio, Lepore, Vito, D'Ettorre, Antonio, Lucisano, Giuseppe, De Berardis, Giorgia, Bisceglia, Lucia, Tognoni, Gianni, Nicolucci, Antonio

“…to develop and validate the Drug Derived Complexity Index (DDCI), a predictive model derived from drug prescriptions able to stratify the general population…”
Get full text

Systematic review of trials using vasodilators in pulmonary arterial hypertension: Why a new approach is needed by Macchia, Alejandro, MD, Marchioli, Roberto, MD, Tognoni, Gianni, MD, Scarano, Marco, MS, Marfisi, RosaMaria, MS, Tavazzi, Luigi, MD, Rich, Stuart, MD

“…Background In a previous metaanalysis on the approved treatments for pulmonary hypertension, we reported that all therapies caused small changes in 6-minute…”
Get full text

Cardiovascular mortality and morbidity burden in successive and age pre-stratified case–control cohorts of breast cancer women. A population-based study by Staszewsky, Lidia, Robusto, Fabio, Lepore, Vito, Bisceglia, Lucia, Petrarolo, Vito, D’Ettorre, Antonio, Tognoni, Gianni, Latini, Roberto

“…Aims To assess the existence, components and clinical relevance of cardiac causes of death and cardiovascular (CV) hospitalizations in a population-wide…”
Get full text